UTAH MEDICAL PRODUCTS INC (UTMD) Stock Price & Overview

NASDAQ:UTMDUS9174881089

Current stock price

63.28 USD
+0.64 (+1.02%)
At close:
65.12 USD
+1.84 (+2.91%)
After Hours:

The current stock price of UTMD is 63.28 USD. Today UTMD is up by 1.02%. In the past month the price decreased by -0.71%. In the past year, price increased by 10.44%.

UTMD Key Statistics

52-Week Range51.26 - 68.71
Current UTMD stock price positioned within its 52-week range.
1-Month Range62.22 - 68.71
Current UTMD stock price positioned within its 1-month range.
Market Cap
201.863M
P/E
17.88
Fwd P/E
N/A
EPS (TTM)
3.54
Dividend Yield
1.98%

UTMD Stock Performance

Today
+1.02%
1 Week
-2.83%
1 Month
-0.71%
3 Months
+8.92%
Longer-term
6 Months +1.56%
1 Year +10.44%
2 Years -11.01%
3 Years -33.23%
5 Years -26.93%
10 Years +1.18%

UTMD Stock Chart

UTAH MEDICAL PRODUCTS INC / UTMD Daily stock chart

UTMD Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to UTMD. When comparing the yearly performance of all stocks, UTMD is one of the better performing stocks in the market, outperforming 71.65% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

UTMD Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to UTMD. Both the health and profitability get an excellent rating, making UTMD a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

UTMD Earnings

Next Earnings DateApr 27, 2026
Last Earnings DateFeb 3, 2026
PeriodQ3 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

UTMD Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

UTMD Groups

Sector & Classification

UTMD Financial Highlights

Over the last trailing twelve months UTMD reported a non-GAAP Earnings per Share(EPS) of 3.54. The EPS decreased by -17.3% compared to the year before.


Income Statements
Revenue(TTM)38.63M
Net Income(TTM)11.62M
Industry RankSector Rank
PM (TTM) 30.08%
ROA 9.53%
ROE 9.83%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-19.91%
Sales Q2Q%-1.93%
EPS 1Y (TTM)-17.3%
Revenue 1Y (TTM)-12.35%

UTMD Ownership

Ownership
Inst Owners69.69%
Shares3.19M
Float2.96M
Ins Owners7.18%
Short Float %3.52%
Short Ratio7.03

UTMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
MDLN MEDLINE INC-CL A27.7853.953B
COO COOPER COS INC/THE13.9813.954B
ALGN ALIGN TECHNOLOGY INC14.2711.898B
SOLV SOLVENTUM CORP10.1611.471B
LNTH LANTHEUS HOLDINGS INC14.725.196B
MMSI MERIT MEDICAL SYSTEMS INC16.884.051B
ICUI ICU MEDICAL INC15.213.18B
HAE HAEMONETICS CORP/MASS11.152.764B
XRAY DENTSPLY SIRONA INC7.872.357B
NEOG NEOGEN CORP26.82.034B
UFPT UFP TECHNOLOGIES INC201.575B
STAA STAAR SURGICAL CO133.29914.719M
BVS BIOVENTUS INC - A11.04711.736M

About UTMD

Company Profile

UTMD logo image Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.

Company Info

IPO: 1982-12-01

UTAH MEDICAL PRODUCTS INC

7043 S 300 West

Midvale UTAH 84047 US

CEO: Kevin L. Cornwell

Employees: 155

UTMD Company Website

UTMD Investor Relations

Phone: 18015215301

UTAH MEDICAL PRODUCTS INC / UTMD FAQ

What does UTAH MEDICAL PRODUCTS INC do?

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The firm produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.


What is the stock price of UTAH MEDICAL PRODUCTS INC today?

The current stock price of UTMD is 63.28 USD. The price increased by 1.02% in the last trading session.


Does UTAH MEDICAL PRODUCTS INC pay dividends?

UTAH MEDICAL PRODUCTS INC (UTMD) has a dividend yield of 1.98%. The yearly dividend amount is currently 1.22.


What is the ChartMill technical and fundamental rating of UTMD stock?

UTMD has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the valuation of UTAH MEDICAL PRODUCTS INC (UTMD) based on its PE ratio?

The PE ratio for UTAH MEDICAL PRODUCTS INC (UTMD) is 17.88. This is based on the reported non-GAAP earnings per share of 3.54 and the current share price of 63.28 USD.


When is the next dividend date for UTAH MEDICAL PRODUCTS INC (UTMD)?

The next ex-dividend date for UTAH MEDICAL PRODUCTS INC (UTMD) is March 17, 2026.


What is the market capitalization of UTMD stock?

UTAH MEDICAL PRODUCTS INC (UTMD) has a market capitalization of 201.86M USD. This makes UTMD a Micro Cap stock.